GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » 3-Year Revenue Growth Rate

Fuan Pharmaceutical (Group) Co (SZSE:300194) 3-Year Revenue Growth Rate : 2.10% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co 3-Year Revenue Growth Rate?

Fuan Pharmaceutical (Group) Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.66.

During the past 12 months, Fuan Pharmaceutical (Group) Co's average Revenue per Share Growth Rate was 6.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -1.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 16.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Fuan Pharmaceutical (Group) Co was 44.10% per year. The lowest was -57.00% per year. And the median was 3.50% per year.


Competitive Comparison of Fuan Pharmaceutical (Group) Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuan Pharmaceutical (Group) Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's 3-Year Revenue Growth Rate falls into.



Fuan Pharmaceutical (Group) Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Fuan Pharmaceutical (Group) Co  (SZSE:300194) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Fuan Pharmaceutical (Group) Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines